We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Targeting the Dopamine Receptor Pathway To Treat AML

Article   Mar 03, 2021

 
Targeting the Dopamine Receptor Pathway To Treat AML

Kate Robinson

Editorial Assistant

 
 
Advertisement
 

RELATED ARTICLES

Cancer Drug Discovery: A Molecular Journey to Targeted Treatment

Article

Cancer drug discovery has made great advances since its earliest steps. Although cytotoxic chemotherapeutics remain a mainstay for certain cancer types, the field has been transformed by the advent of molecular techniques. Cytotoxic drugs affect healthy cells, as well as the tumor, and thus give rise to a multitude of side effects. To counter this, the focus has shifted to more targeted approaches by leveraging molecular characteristics that are more unique to the tumor than healthy cells.

READ MORE

How Can We Take Advantage of Ketamine’s “Window of Opportunity?”

Article

At the British Neuroscience Association’s 2021 Festival of Neuroscience, a session was devoted to the discussion of new research working towards understanding ketamine’s mechanism of action and its potential use as a treatment for alcohol use disorder.

READ MORE

The Coronavirus Pandemic

Article

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to what has become the COVID-19 pandemic.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE